about
Nodular Regenerative Hyperplasia: A Case of Rare PrognosisHaptoglobin expression correlates with tumor differentiation and five-year overall survival rate in hepatocellular carcinomaHepatocellular carcinoma surgery outcomes in the developing world: A 20-year retrospective cohort study at the National Cancer Institute of Peru.Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinomahsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinoma.Chemical inhibition reveals differential requirements of signaling pathways in krasV12- and Myc-induced liver tumors in transgenic zebrafish.Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma.Hypoxia inducible factors in hepatocellular carcinomaPotential ultrastructure predicting factors for hepatocellular carcinoma in HCV infected patients.Automatic quantification of morphological features for hepatic trabeculae analysis in stained liver specimens.Micro-HCCs in rats with liver cirrhosis: paradoxical targeting effects with vascular disrupting agent CA4P.Synergistic effect of farnesyl transferase inhibitor lonafarnib combined with chemotherapeutic agents against the growth of hepatocellular carcinoma cells.Phytochylomicron as a dual nanocarrier for liver cancer targeting of luteolin: in vitro appraisal and pharmacodynamics.Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development.The clinicopathological significance of miR-149 and PARP-2 in hepatocellular carcinoma and their roles in chemo/radiotherapy.Expression of receptor interacting protein 1 and receptor interacting protein 3 oval cells in a rat model of hepatocarcinogenesis.Intra-individual comparison of therapeutic responses to vascular disrupting agent CA4P between rodent primary and secondary liver cancers.Reactive Ductules Are Associated With Angiogenesis and Tumor Cell Proliferation in Pediatric Liver CancerTumoral response and tumoral phenotypic changes in a rat model of diethylnitrosamine-induced hepatocellular carcinoma after salirasib and sorafenib administrationMucin-producing hepatocellular carcinoma without morphological features of biliary differentiation: A case report
P2860
Q33441754-D2AA05EB-ED59-49AA-8340-B026C79F943DQ36270131-C8D90AAC-585F-42C0-BFDF-F5C92A16B761Q37096406-1C52DB2F-2BF0-4717-9090-9C8DFB7E47FEQ37636703-4EBDD056-7691-41F4-88F2-F17440B099E3Q37685458-2C7E3EBB-AFA4-4614-8B4C-D144AFC72594Q37738003-1D758B2C-AF81-47A6-BDF2-08EB7AFC955AQ38635603-478226A5-E062-4ABF-8545-E686854F3E3DQ38685135-BDEDFD3B-5A78-4868-8122-CF1D152EE5C5Q39212821-DFD2D54F-1B6A-473B-AF7E-05B1FAB6D4AFQ40384397-04CCC6A0-0514-48A4-A460-47B8F822DB27Q41549134-5A1A3C46-7C3F-45D0-8758-A8E397044691Q47094177-F566964C-2EF1-4A79-8ECC-7A5E3607C900Q49330500-EFFB13F3-C42D-46C2-BCD8-04524803B81AQ49788208-D265BDFF-53DC-411E-8A65-6EE74C5B1078Q51703634-A62B45F6-A3D2-477E-9E2C-84C01FAF1905Q54219830-1BC296A2-D443-440C-BA8F-0A9EB32888B3Q55506772-8F4CB94B-EE8B-402D-AE59-5181C893F02CQ57069778-F5B03070-70EF-43DF-B2AC-3D34B65B7087Q58547786-B07C400F-A115-433F-9B8B-823AA5F8B138Q58759122-07C8014B-DD7F-4522-AE38-3A0D66382FCA
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Histopathology of hepatocellular carcinoma
@ast
Histopathology of hepatocellular carcinoma
@en
Histopathology of hepatocellular carcinoma
@nl
type
label
Histopathology of hepatocellular carcinoma
@ast
Histopathology of hepatocellular carcinoma
@en
Histopathology of hepatocellular carcinoma
@nl
prefLabel
Histopathology of hepatocellular carcinoma
@ast
Histopathology of hepatocellular carcinoma
@en
Histopathology of hepatocellular carcinoma
@nl
P2093
P2860
P1476
Histopathology of hepatocellular carcinoma
@en
P2093
Luigi Maria Terracciano
Manuel Schlageter
Paolo Sorrentino
Salvatore D'Angelo
P2860
P304
15955-15964
P356
10.3748/WJG.V20.I43.15955
P407
P577
2014-11-01T00:00:00Z